A detailed history of Cibc Private Wealth Group, LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 835 shares of CORT stock, worth $48,045. This represents 0.0% of its overall portfolio holdings.

Number of Shares
835
Previous 855 2.34%
Holding current value
$48,045
Previous $27,000 40.74%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$29.51 - $46.26 $590 - $925
-20 Reduced 2.34%
835 $38,000
Q2 2024

Aug 09, 2024

SELL
$22.21 - $34.48 $4,886 - $7,585
-220 Reduced 20.47%
855 $27,000
Q1 2024

May 10, 2024

BUY
$21.1 - $27.46 $22,682 - $29,519
1,075 New
1,075 $27,000

Others Institutions Holding CORT

About CORCEPT THERAPEUTICS INC


  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $6.16B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Cibc Private Wealth Group, LLC Portfolio

Follow Cibc Private Wealth Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Private Wealth Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Private Wealth Group, LLC with notifications on news.